Objective: The objective of the study was to review the evidence for the effectiveness of telephone psychotherapy on psychological outcomes in people with multiple sclerosis (MS). Method: We conducted a systematic search of EMBASE, PsycINFO, PsycARTICLES, MEDLINE, CINAHL, Web of Science, and hand-searched relevant journals to identify randomized controlled trials (RCTs) that evaluated the effectiveness of telephone psychotherapy on psychological outcomes in people with MS (last search completed on October 1, 2015). The methodological quality of each included trial was assessed, based on a standardized list of methodological criteria. Where available, data were extracted and combined in a meta-analysis to compute effect size estimates. Results: Eleven RCTs and 1,104 participants were identified. The meta-analysis found a moderate effect of the intervention on depression (SMD 0.47 [95% confidence interval 0.21-0.73]). The meta-analysis also found small to moderate short-term effects of the intervention on fatigue, quality of life, MS symptoms, physical activity, and medication adherence, compared with controls and other interventions. RCT designs were heterogeneous. All studies had at least 1 high or unclear risk of bias. Conclusions: Telephone psychotherapy provides small and moderate benefits in depression, fatigue, quality of life, MS symptoms, physical activity, and medication adherence in the short term. Few gains were sustained in the long term. Studies of better quality are needed.
Introduction
Multiple sclerosis (MS) is a progressive neurological condition with no cure that affects 2.5 million people worldwide (MS Trust, 2015) . The majority of those with MS have a relapsing-remitting form, whereby symptoms develop during a relapse, typically lasting 2-6 weeks, before remitting. Symptoms can become permanent and the condition can become worse over time, which is called secondary progressive MS (National Institute for Clinical Excellence, 2003) . MS can have diverse and unpredictable effects on physical and psychological functioning (Wilkinson & Nair, 2013) , so there is a need for accessible and effective psychotherapeutic support. Psychological and psychosocial problems frequently arise in areas such as physical functioning, fatigue, pain, cognition, and problems with the support they receive from people around them (Khan, Turner-Stokes, Ng, & Kilpatrick, 2007) . These types of problems are thought to be highly prevalent in the MS population. The lifetime prevalence of depression in MS, for instance, is estimated at 50% (National Institute for Clinical Excellence, 2003) , compared with 17% in a nonclinical population (Blazer, Kessler, McGonagle, & Swartz, 1994) . Psychosocial distress may arise through various interacting pathways, making the precise etiology of psychological distress difficult to discern. This document is copyrighted by the American Psychological Association or one of its allied publishers. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
Many people with MS already take multiple medications for their condition and physical sequelae, and the pharmacological management of mood problems adds to their medical regimen. Psychotherapy, which has the potential to be effective in this population (Thomas, Thomas, Hillier, Galvin, & Baker, 2006) , may provide an alternative treatment of choice for many. However, those with MS may not be able to access face-to-face psychological therapies because of fatigue, reduced mobility, and other condition-related limitations. Furthermore, clinical experience suggests that psychological interventions may be perceived as costly and therefore not always funded by health care providers. Therefore, research into other ways of making such care available is warranted.
Telephone psychotherapy is an intervention that offers the opportunity to deliver psychological therapies to people in their own homes who otherwise might find it difficult to travel to a health care location to receive face-to-face therapy, or where there are limited resources to allow therapists to conduct home visits. Previous systematic reviews have demonstrated the potential effectiveness of telephone-based interventions across a broad range of physical (Hailey, Roine, Ohinmaa, & Dennett, 2011) and mental health domains (Leach & Christensen, 2006) , including stroke (Johansson & Wild, 2011; Paré, Jaana, & Sicotte, 2007) and spinal cord injury (Dorstyn, Mathias, & Denson, 2013; Hailey, Roine, Ohinmaa, & Dennett, 2013) . Telephone psychotherapy is thought to work in a similar way to face-to-face delivered psychotherapy but may provide lower attrition rates (Mohr, Vella, Hart, Heckman, & Simon, 2008) . Client satisfaction and acceptance of telephone psychotherapy has also been found to be high (Bee et al., 2008) . There are studies that have explored the usefulness of telephone psychotherapy, however, there is no consensus as to whether it can provide a similar quality of care compared with face-to-face interventions at a reduced cost (Mistry, 2012) .
To our knowledge, there is no systematic review that evaluates the clinical effectiveness of telephone psychotherapies on psychological outcomes in MS. Results from this review will direct future research and practice on the potential applicability of this type of intervention with people with MS.
This systematic literature review aims to determine the effectiveness of telephone-based psychotherapies for people with MS, compared with those receiving no treatment, standard care, or other control, on psychological and physical outcomes.
Method
We searched the following electronic databases (from inception to October 1, 2015) to identify potential studies: EMBASE, PsycINFO, PsycARTICLES, MEDLINE, CINAHL, and Web of Science. The search strategy was based around the subjects: MS, telephone-based psychotherapies, and randomized controlled trials (RCTs). An example of the search strategy is presented in the Appendix. Manual citation tracking of all primary studies, forward citation tracking, and scanning references lists from review articles were conducted as another search strategy. The World Health Organization International Clinical Trials Registry Platform and www.clinicaltrials.com were searched to identify registered trials that met the inclusion criteria but with no data published. If any trials appeared to meet the inclusion criteria, the authors were contacted to request their data.
Trials including people with MS in which a telephone-delivered psychological therapy was compared with a control were sought for inclusion in the review. RCTs and the precrossover component of randomized crossover trials were considered for inclusion if they met other criteria. Papers reporting a secondary analysis of studies were included if they included between-group comparisons of outcomes of interest not reported in the original paper. Studies from conference presentations, dissertations, or other gray literature were excluded.
We included trials with patients with all subtypes of MS. Trials with mixed-diagnosis populations in which MS data were not separable were excluded. Trials in which there was a comparison between a treatment group that received a telephone-based psychological therapy and a control group that either received no intervention or another type of intervention were included. To be considered a psychological therapy, the interventions should have been described as wholly or partially based on established psychological theories, models, or principles. Therapy was considered to consist of a minimum of four sessions to eliminate evaluations of telephone hotlines or crisis counseling services. Studies that delivered therapy via video-conference technologies were excluded and studies that delivered support via web/Internet technologies This document is copyrighted by the American Psychological Association or one of its allied publishers.
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without adjunct teletherapy were excluded; therapy using technology that allows the client and therapist to see each other can bring both challenges and advantages different to solely audio-only therapies (Simpson, 2009 ). Therapies could be delivered by any trained clinician (e.g., doctors, nurses, therapists). The primary outcome of interest was depression. If there was more than one outcome measure determining this construct, we used the following hierarchy of commonly used tests:
(a) Beck Depression Inventory (BDI; Beck, Steer, & Carbin, 1988) .
(b) Hamilton Depression Rating Scale (HDRS; Hamilton, 1960) .
(c) Any other depression outcomes. Secondary outcomes were anxiety, fatigue, quality of life (QOL), MS symptoms, medication adherence, and level of physical activity.
All outcomes were either defined as short-term or long-term. Short-term outcomes were assessed immediately after the intervention. Long-term outcomes were defined as the outcome assessed nearest to 12 months after the randomization, within a range of 6 -18 months. Separate analyses were conducted for each of these time points where possible. Total scores were taken over domain scores (subtest sections) if both were available. If subscale scores were reported without total scale scores, then first individual effect sizes were calculated for each subscale and then combined using the method of Rosenthal and Rubin (Rosenthal & Rubin, 1986) for computing accurate combination of effect sizes incorporating the estimated intercorrelation between the subscales. Self-report scores were taken over clinician-rated scores if both were available.
Included trials were assessed for methodological quality and rated using the Risk of Bias Table from the Cochrane Handbook for Systematic Reviews of Interventions, guidelines 5.1.0 (Higgins & Green, 2008) . Potential sources of bias were judged to be low risk, high risk, or unclear risk by one researcher (B.P.) and independently checked by another researcher (W.V.). R.d.N. and N.M. arbitrated if there were any discrepancies. An overall evaluation of the risk for all included studies was completed.
The review was conducted using the Cochrane Review Manager software, RevMan 5.3 (The Cochrane Collaboration, 2014). Standardized mean difference (SMD) was used as a summary statistic.
Only data that were deemed to be similar or comparable enough to meaningfully pool, on the basis of the outcome measures, were entered into the meta-analysis. Depending on the heterogeneity of the data, fixed-effect or random-effects models were considered. Where continuous data were available, means and standard deviations were entered into RevMan (The Cochrane Collaboration, 2014) , and the effect estimate (with 95% confidence intervals) was calculated using the inverse variance method to apply a weighting to each analysis and displayed as an SMD. Where data were dichotomous, a Mantel-Haenszel analysis was completed to produce an odds ratio effect estimate, with 95% confidence intervals.
Where medians with upper and lower quartiles were reported, medians were treated as means and interquartile ranges were used to estimate the SD, according to the following formula: SD ϭ interquartile range/1.35.
The data were estimated to be of an approximately normal distribution if, by subtracting the lowest value on each scale from the estimated median and dividing this by the estimated SD, the value produced was higher than one. The I 2 statistic (Higgins & Green, 2008) was used to assess heterogeneity in a meta-analysis.
Results
A description of the included studies can be seen in Table 1 . A total of 125 studies were identified after removing duplicates. Based on our inclusion criteria, 11 studies (comprising 1,104 participants) were included in the review. Of these, 10 studies This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
(1,032 participants) were included in the meta-analyses (Berger et al., 2005; Bombardier et al., 2008 Bombardier et al., , 2013 Cosio et al., 2011; Egner et al., 2003; Finlayson et al., 2011; Mohr et al., 2000 Mohr et al., , 2005 Mohr et al., , 2007 Turner et al., 2014) . The PRISMA (Liberati et al., 2009 ) diagram in Figure 1 details the flow of the search strategy and reasons for exclusion. Overall, the risk of bias was mixed across the 11 included studies, detailed in Table 2 and summarized in Figures 2 and 3 . Interrater reliability (Kappa) analysis indicated perfect agreement on quality ratings ( ϭ 1).
Comparisons were split into two categories: comparisons of telephone-psychotherapy to waiting lists or no intervention controls, and comparisons of Telephone Cognitive-Behavior Therapy (T-CBT) to Telephone Support Emotion-Focused Therapy (T-SEFT).
Of the included studies, one was not considered for the metaanalysis: The Baron study (Baron et al., 2011) was not included because it did not present sufficient data on between-group differences. It reported no significant difference between the T-CBT and T-SEFT groups on insomnia, measured using the three insomnia subitems of the HDRS (Hamilton, 1960) .
Comparisons of Interventions to Waiting List or No Intervention Controls
Depression. Three studies (Bombardier et al., 2013; Egner et al., 2003; Mohr et al., 2000) included short-term measures of depression using the HDRS (Hamilton, 1960) , the Centre for Epidemiologic Studies Depression Scale (Orme, Reis, & Herz, 1986) , and the BDI (Beck et al., 1988) . A moderate effect on depression was found (SMD 0.47 [95% confidence interval (CI) of 0.21-0.73]), as seen in Figure 4 below. Statistical heterogeneity assessed using I 2 was 0%. The Egner study (Egner et al., 2003) included the long-term measurement of depression using the Centre for Epidemiologic Studies Depression Scale (Orme et al., 1986) . A small nonsignificant treatment effect was found on depression favoring the control group (SMD Ϫ0.33 [95% CI Ϫ1.22 to 0.56]).
Fatigue. The Finlayson study (Finlayson et al., 2011 ) reported short-term effect estimates and standard errors for three subscales of the Fatigue Impact Scale (Fisk, Pontefract, Ritvo, Archibald, & Murray, 1994) . The three subscales were converted into effect sizes and averaged, taking into account the subscale intercorrelation of 0.87 . A moderate composite effect size was found in favor of the intervention (SMD 0.49 [95% CI 0.82-0.17]). One of the two Bombardier studies (Bombardier et al., 2008) and the Egner study (Egner et al., 2003) reported short-term continuous data on fatigue using the Modified Fatigue Impact Scale and the Fatigue Severity Scale (Krupp, LaRocca, Muir-Nash, & Steinberg, 1989) . A small nonsignificant effect favoring the control was found (SMD Ϫ0.31 [95% CI Ϫ0.63 to 0.02]), as seen in Figure 5 below. Statistical heterogeneity assessed using I 2 was 0%. The Egner study (Egner This article is intended solely for the personal use of the individual user and is not to be disseminated broadly. et al., 2003) reported on the long-term effects on fatigue on the Fatigue Severity Scale (Krupp et al., 1989) , with no effect found (SMD 0.00 [95% CI of Ϫ0.95 to 0.95]). Quality of life. Two studies (Bombardier et al., 2008; Egner et al., 2003) reported short-term data on QOL using the Short Form 36 measure (Jenkinson, Coulter, & Wright, 1993 ) and the Quality of Wellbeing Scale (McDowell, 2006) . No effect was found (SMD 0.05 [95% CI Ϫ0.27 to 0.38]), as shown in Figure 6 below. Statistical heterogeneity assessed using I 2 was 0%. The Egner study (Egner et al., 2003) reported long-term continuous data on QOL, using the Quality of Wellbeing Scale (McDowell, 2006) , finding no effect (SMD 0.00 [95% CI Ϫ0.95 to 0.95]).
Medication adherence. The Berger study (Berger et al., 2005) reported dichotomous data on medication adherence: the number of participants who had stopped taking their medication. A significant but negligible effect was found ). The Turner study (Turner et al., 2014) reported continuous data on medication adherence, asking how often participants had missed doses in the last month. A small nonsignificant effect was found in favor of the intervention (SMD 0.33 [95% CI Ϫ0.6 to 1.27]). The same study reported long-term effects of medication adherence, finding a large but nonsignificant effect in favor of the intervention (SMD 0.89 [95% CI Ϫ0.09 to 1.88]).
Physical health. Both Bombardier studies (Bombardier et al., 2008 (Bombardier et al., , 2013 reported data on the short-term effects on physical health, using the Health Promotion Lifestyles Profile (Walker, Sechrist, & Pender, 1987) and the 7-day physical activity recall measure (Sallis et al., 1985) . A small effect was found favoring the intervention ), as seen in Figure 7 below. Statistical heterogeneity assessed using I 2 was 0%. One Bombardier study (Bombardier et al., 2013 ) included shortterm measures of MS symptoms using the MS-Related Symptoms Checklist (Gulick, 1989) . A moderate effect was found favoring the intervention ).
Comparisons of T-CBT and T-SEFT
One Mohr study (Mohr et al., 2005 ) included short-term measures of depression, using the BDI (Beck et al., 1988) . A small nonsignificant effect was found favoring the T-CBT (SMD 0.33 [95% CI Ϫ0.03 to 0.69]) compared with the T-SEFT. The same study included long-term measures of depression, using the BDI (Beck et al., 1988) . No effect was found favoring either intervention (SMD 0.06 [95% CI Ϫ0.3 to 0.43]).
One Mohr study reported on short-term measures of fatigue, using the Fatigue Impact Scale (Fisk, Pontefract, et al., 1994) . A small nonsignificant effect was found favoring T-CBT over T-SEFT (SMD 0.18 [95% CI Ϫ0.18 to 0.54]).
The Cosio study (Cosio et al., 2011 ) included short-term measures of QOL, which was a single-item question about QOL. A moderate effect favoring the T-CBT over the T-SEFT was found 
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Discussion
There is some mixed and poor-quality evidence that suggests that providing telephone psychotherapy to people with MS has small to moderate benefits on depression, fatigue, physical activ-
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ity, medication adherence, and MS symptoms in the short term. This finding appears to be approximately comparable with other systematic reviews of telephone therapies in chronic and neurological populations (Hailey et al., 2011; Johansson & Wild, 2011; Leach & Christensen, 2006) , which also offer tentative evidence for the potential effectiveness of the intervention.
Where follow-up data were available, initial gains were not sustained in the long term after the termination of telephone psychotherapy. The results suggest there is some mostly poorquality evidence that providing T-CBT over T-SEFT will have small benefits on short-term QOL.
Overall, the majority of trials were of poor quality, with no studies fully adhering to the Consolidated Standards of Reporting Trials (CONSORT) guidelines (Moher, Schulz, & Altman, 2001 ). Mostly of small and moderate sample sizes, the majority of RCTs had high or unclear risks of selection bias and performance bias. More than half had a low risk of detection bias. However, attrition, reporting, and other biases were relatively low. All studies had at least one high or unclear risk of bias.
Like other systematic reviews, there is risk of potential publication bias. Any RCTs without positive results may not have been picked up by the search strategy. The results of this study support the notion that many psychological variables in MS are correlated because telephone psychotherapy produced similar effects across different outcomes. Other psychosocial and functional outcomes may respond to similarly to telephone psychotherapy. Because of limited data, subanalyses on how subtype of MS diagnosis, frequency of telephone calls, or theoretical approach of therapy may interact with telephone psychotherapy were not conducted. Future research may address these areas in the hope of exploring what formats of therapy are most effective for whom.
Almost all studies were based on a specific psychological theory or model, commonly motivational interviewing or cognitive behavior therapy, and demonstrate a similar small effect on psychological outcomes. However, the intervention in one trial (Finlayson et al., 2011) only very briefly alluded to cognitive-behavioral principles and it was not at all explicit. Nevertheless, one could cautiously conclude that the specific theoretical modality of the telephone support offered does not impact significantly upon outcome, much like face-to-face psychotherapy (Wampold et al., 1997) . Although little evidence exists, it may be the case that, like face-to-face therapy (Norcross, 2002) , telephone psychotherapy emphasizes the therapeutic alliance for outcome change. Evidence for this comes from a study in which better therapeutic alliance was found to predict better outcomes in telephone psychotherapy for people with MS and depression (Beckner, Vella, Howard, & Mohr, 2007) . Therapeutic alliance may feasibly be modified by frequency and intensity of telephone calls.
Overall, the current literature on telephone psychotherapy for people with MS is sparse and methodologically poor, with most trials not adhering to CONSORT guidelines (Moher et al., 2001 ). Clinicians and researchers may recognize that telephonepsychotherapy interventions can have small to moderate shortterm effects on mental and physical well-being. However, more well-conducted and reported RCTs following published guidance in this area are needed. Although not possible in this review because of small sample sizes and lack of information of diagnosing criteria, future reviews may also attempt to conduct subgroup analyses by MS subtype or level of disability, theoretical approach, and frequency/intensity of telephone support. Given potential advantages in terms of increased accessibility and reduced cost in telephone-based psychotherapy, findings to date warrant further investigation.
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